VanEck Pharmaceutical ETF - USD Stock

ETF

PPH

US92189F6925

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
108.06 ^USD	-0.07%		-2.95%	+4.74%

09-29	VanEck ETF Trust - VanEck Pharmaceutical ETF announces Quarterly dividend, payable on October 06, 2026	CI
06-29	VanEck ETF Trust - VanEck Pharmaceutical ETF announces Quarterly dividend, payable on July 07, 2026	CI

Chart: VanEck Pharmaceutical ETF - USD

NasdaqUSD

Markets		Quality
Nasdaq	PPH	Delayed
CBOE	PPH	Real-time
Tradegate	VEFV	Real-time
Boerse Muenchen	VEFV	Real-time

Dynamic Chart

Investment objective

VanEck Vectors Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Composition of VanEck Pharmaceutical ETF - USD

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Off-Hours Price	Change	YTD change	Weight
ELI LILLY AND COMPANY	1,142.85USD	-0.61%	+6.34%	18.69%
MERCK & CO., INC.	144.30USD	+0.34%	+37.09%	9.53%
MCKESSON CORPORATION	902.28USD	+0.38%	+10.00%	4.9%
BRISTOL-MYERS SQUIBB COMPANY	61.15USD	+0.53%	+13.37%	4.88%
JOHNSON & JOHNSON	256.03USD	-1.02%	+23.72%	4.82%
PFIZER INC.	27.80USD	-1.14%	+11.65%	4.78%
ASTRAZENECA PLC	11,870.00GBX	-1.35%	-13.92%	4.52%

See all (24)

All the latest ETF news

10-02	US-listed ETFs on course for record annual inflows, State Street says	RE
10-02	US equity funds post second weekly inflow as AI optimism tempers yield concerns	RE
10-02	Global equity funds draw inflows for second week as AI optimism holds	RE
10-02	Simplicity High Yield fell 0.04 percent in September - primary market remained relatively strong	FW
10-01	Fuh Hwa Taiwan Technology Dividend Highlight ETF announces Monthly dividend, payable on November 16, 2026	CI
10-01	Vanguard Specialized Funds - Vanguard Real Estate ETF Reports Earnings Results for the Half Year Ended July 31, 2026	CI
10-01	HSBC lowers 2026 average gold price forecast to $4,490/oz	RE
10-01	Entrenched premium leaves gold primed to climb despite surge in US bond yields	RE

More news

In partnership with

Quotes

Date	Price	Change	Volume
26-10-02	US$108.06	-0.07%	272,521
26-10-01	US$108.14	-1.21%	365,895
26-09-30	US$109.47	-1.48%	544,703
26-09-29	US$111.11	-0.33%	520,120
26-09-28	US$111.48	+0.12%	499,725

Delayed Quote Nasdaq

More quotes

Description

	US92189F6925
Total Expense Ratio	0.0036
Asset Class	Stocks
Sector	Pharmaceuticals
Currency	USD
Provider	VanEck
Underlying	MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD
Autres ETFs